Parametric Portfolio Associates’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
GCM
SUT
Parametric Portfolio Associates's CELL Position: Q1 2022 in Review
Parametric Portfolio Associates reduced its PhenomeX Inc. Common Stock (CELL) stake by 17% in Q1 2022, selling an estimated $24.2K and leaving 14,133 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #3562.
Parametric Portfolio Associates first reported a position in CELL in Q4 2020 and has held it in 5 quarters since. The position peaked at $551K in Q2 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.
- Parametric Portfolio Associates held 14,133 shares of PhenomeX Inc. Common Stock worth $100K as of Q1 2022.
- Parametric Portfolio Associates sold 2,931 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $24.2K.
- PhenomeX Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3562 holding.
- Parametric Portfolio Associates first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and has held it in 5 quarters since.
- Parametric Portfolio Associates's PhenomeX Inc. Common Stock position peaked at $551K in Q2 2021.
- 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.